Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ulcerative colitis: an immunological disease?

G Radford-Smith1

  • 1Department of Gastroenterology, Royal Brisbane Hospital, Queensland, Australia.

Bailliere'S Clinical Gastroenterology
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drain fluid amylase as a sensitive biomarker for the early detection of anastomotic leakage in ileal pouch surgery.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018
Same author

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Alimentary pharmacology & therapeutics·2017
Same author

Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation.

Mucosal immunology·2017
Same author

Granzyme M has a critical role in providing innate immune protection in ulcerative colitis.

Cell death & disease·2016
Same author

Review article: acute severe ulcerative colitis - evidence-based consensus statements.

Alimentary pharmacology & therapeutics·2016
Same author

Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis.

Alimentary pharmacology & therapeutics·2015

Ulcerative colitis involves an abnormal immune response in the large intestine. Further research is needed to understand the initial immune triggers and antigen presentation in the mucosa that cause T and B cell activation.

Area of Science:

  • Immunology
  • Gastroenterology

Background:

  • Ulcerative colitis is a large intestine inflammatory disease with unknown causes.
  • The inflammatory response and corticosteroid treatment suggest immune system involvement.
  • The primary cause—mucosal breach versus immune defect—remains unclear.

Purpose of the Study:

  • To investigate the role of immune system abnormalities in ulcerative colitis.
  • To identify critical early mucosal interactions involving antigen processing and presentation.
  • To pinpoint defects leading to heightened T and B cell activation.

Main Methods:

  • Analysis of inflammatory infiltrate in ulcerative colitis.
  • Assessment of immune cell responses, including T and B cells.
  • Investigation of antigen processing and presentation within the colonic mucosa.

Related Experiment Videos

Main Results:

  • T and B cell compartments are implicated in sustaining ulcerative colitis inflammation.
  • Initial mucosal antigen processing and presentation mechanisms require further investigation.
  • Specific defects triggering T and B cell activation are not yet fully identified.

Conclusions:

  • Ulcerative colitis pathogenesis involves complex immune dysregulation.
  • Understanding early mucosal immune events is crucial for identifying therapeutic targets.
  • Further research is essential to elucidate the precise triggers of immune activation in ulcerative colitis.